On the other hand, we found a reduction in genes associated with the NF-κB signaling pathway (Fig. 2G), hinting that G9a inhibition could reduce neuroinflammation in the late-onset AD mouse model. The gene discussed is EHMT2; the disease is Alzheimer disease.